Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246400 · ClinicalTrials.gov registry record · NA
CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact
A NA study, sponsored by Palo Alto Medical Foundation.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT02246400 is a NA study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 74 participants.
The verdict
NCT02246400, a NA study, has completed, sponsored by Palo Alto Medical Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The eCMP Pilot aims to study the feasibility and potential effectiveness of an electronically-mediated CardioMetabolic Program (eCMP) for therapeutic lifestyle change among adults with or at high risk for type 2 diabetes, heart disease, and/or stroke.
Interventions
- BEHAVIORAL eCMP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02246400
The ClinicalTrials.gov registry entry for NCT02246400 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Medical Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eCMP is the first listed.
NCT02246400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02246400 about?
NCT02246400 is a clinical study titled "CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact". The eCMP Pilot aims to study the feasibility and potential effectiveness of an electronically-mediated CardioMetabolic Program (eCMP) for therapeutic lifestyle change among adults with or at high risk for type 2 diabetes, heart disease, and/or stroke.
What is the current status of trial NCT02246400?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2014-01. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02246400?
The interventions under investigation include: eCMP (BEHAVIORAL).
Who is sponsoring clinical trial NCT02246400?
This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.